SAB Biotherapeutics, Inc. (SABS) earnings
Quarterly results of SAB Biotherapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
SAB Biotherapeutics, Inc. is expected to report around March 8, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) SAB Biotherapeutics, Inc. reported revenue of - and a net loss of $22.3M.
Diluted earnings per share were -$0.24.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | - | - | -$22.3M | -$0.24 |
| Q2 FY2026 | - | - | -$22.5M | -$0.28 |
| Q1 FY2026 | - | - | -$18.9M | -$0.35 |
| Q4 FY2025 | - | - | -$16.9M | - |
| Q3 FY2025 | - | - | $45.4M | -$0.21 |
| Q2 FY2025 | - | - | -$10.1M | -$1.09 |
| Q1 FY2025 | - | - | -$5.2M | -$0.56 |
| Q4 FY2024 | - | - | -$11.4M | - |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
When is SAB Biotherapeutics, Inc.'s next earnings date?
SAB Biotherapeutics, Inc. is expected to report around March 8, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when SABS reports
Follow SABS and we email you its next results the day they are filed, with the numbers explained.